Potassium (((Tert-butoxycarbonyl)amino)methyl)trifluoroborate - CAS 1314538-55-0
Catalog: |
BB058057 |
Product Name: |
Potassium (((Tert-butoxycarbonyl)amino)methyl)trifluoroborate |
CAS: |
1314538-55-0 |
Synonyms: |
Potassium (((tert-butoxycarbonyl)amino)methyl)trifluoroborate; Potassium N-Boc-aminomethyltrifluoroborate; potassium; trifluoro-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]boranuide; Potassium {[(tert-butoxycarbonyl)amino]methyl}trifluoroborate; POTASSIUM ((TERT-BUTOXYCARBONYLAMINO)METHYL)TRIFLUOROBORATE; potassium tert-butyl N-[(trifluoroboranuidyl)methyl]carbamate |
IUPAC Name: | potassiumtrifluoro-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]boranuide |
Description: | Potassium (((tert-butoxycarbonyl)amino)methyl)trifluoroborate is used in preparation of thienoazepine immunoconjugates for treatment of cancer. |
Molecular Weight: | 237.06 |
Molecular Formula: | C6H12BF3KNO2 |
Canonical SMILES: | [B-](CNC(=O)OC(C)(C)C)(F)(F)F.[K+] |
InChI: | InChI=1S/C6H12BF3NO2.K/c1-6(2,3)13-5(12)11-4-7(8,9)10/h4H2,1-3H3,(H,11,12)/q-1+1 |
InChI Key: | WSOSBCPWIQUNLD-UHFFFAOYSA-N |
References: | Safina, B., et al. PCT Int. Appl., (2021). |
GHS Hazard Statement: | H302 (66.67%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021247809-A1 | PYRAZOLO[4,3-d]PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CELLULAR PROLIFERATIVE DISORDERS | 20200604 |
WO-2021239558-A1 | Pyrazolo[1,5-a]pyrimidine derivatives having multimodal activity against pain | 20200527 |
WO-2021224636-A1 | Antagonists of the adenosine a2a receptor | 20200507 |
WO-2021226003-A1 | Il4i1 inhibitors and methods of use | 20200506 |
WO-2021155264-A1 | Compounds and uses thereof | 20200129 |
US-2021128744-A1 | Thienoazepine immunoconjugates, and uses thereof | 20191025 |
WO-2021081402-A1 | Macromolecule-supported thienoazepine compounds, and uses thereof | 20191025 |
WO-2021081407-A1 | Thienoazepine immunoconjugates, and uses thereof | 20191025 |
US-2020377463-A1 | Macrocyclic broad spectrum antibiotics | 20190528 |
WO-2020243155-A1 | Macrocyclic broad spectrum antibiotics | 20190528 |
Complexity: | 193 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 237.0550248 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 6 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 237.0550248 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 38.3Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS